Contact this trialFirst, we need to learn more about you.
Iron Chelating Agent
Deferiprone for Subarachnoid Hemorrhage
Recruiting0 awardsPhase 1 & 2
Durham, North Carolina
This trial will help assess if De + standard of care can help improve outcomes in SAH patients by reducing iron deposition and ferritin levels in the brain.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service